Recently, Baumann et al. reported that MDSC-dependent metabolites constrain the anti-tumor response of CD8+ T cells via the cell-to-cell transfer of the toxic metabolite methylglyoxal (MG) to the cytosol of T cells [71]. Here, CD8A is linked to neoplasm.